Alterations of upstream effectors of RAS, such as NF1 or SPRED1, in mucosal melanomas could play this role, but there is currently not enough extensive genomic data on mucosal melanoma to confirm this hypothesis [22,53]. The gene discussed is NF1; the disease is mucositis.